维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="SCHLEUNING M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Cyopreservation of human platelets with dimethyl sulfoxide; Changse in biochemistry and cell function 显示文摘	Bock M Schleuning M Helm mu	1995	Transfusion1995，35，：	1
2	Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation显示文摘	Schmid C Schleuning M Schwerdtfeger R	2006	Blood2006，108，3：	1
3	Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease 显示文摘	Wolff D Schleuning M yon Harsdorf S	2011	Biol Blood Marrow Transplant2011，17，1：	1
4	High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission 显示文摘	Schmid C Schleuning M Hentrich M	2008	Bone Marrow Transplant2008，7，：	1
5	Sequential regimen of chemotherapy,reduced-intensity conditioning for allogeneic stem-cell transplantation,and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome显示文摘	Schmid C Schleuning M Ledderose G		0，，：	1
6	Calcineurin inhibitor-free GVHD prophylaxis with sirolimus,mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk:an observational cohort study显示文摘	Schleuning M Judith D Jedlickova Z		0，，：	1
7	Neurological and Neuroradiological Findings in Long Term Survivors of Allogeneic Bone Marrow Transp Lantation显示文摘	Padovan CS Yousry TA Schleuning M	1998	Ann Neurol1998，43，5：	1
8	High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission 显示文摘	Schmid C Schleuning M Hentrich M	2008	Bone Marrow Transplant2008，41，8：	1
9	Cryopreservation of human platelets with dimethyl sulfoxide:changes in biochemistry and cell function显示文摘	B(o)ck M Schleuning M Heim MU	1995	Transfusion1995，35，11：	1
10	Human parvovirus B19-as-sociated disease in bone man:w transplantation 显示文摘	Schleuning M Jager G Holler E	1999	Infection1999，27，2：	1
11	Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome 显示文摘	SCHMID C SCHLEUNING M LEDDEROSE G	2005	J Clin Oncol2005，23，24：	1
12	Allelic dimorphism in the human tissue-type plasminogen activator (t-PA) gene as a result of an Aluinsertion/deletionevent显示文摘	Ludwig M Wohn KD Schleuning WD	1992	HumGenet1992，88，：	1
13	The effect of prior exposure to imatinib on transplant related mortality显示文摘	DEININGER M SCHLEUNING M GREINIX H	2006	Haemato-logica2006，91，：	1
14	Human parvovirus B19-associated disease in bone marrow transplantation 显示文摘	Schleuning M Jager G Holler E	1999	Infection1999，27，2：	1
15	Long term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation显示文摘	SCHMID C SCHLEUNING M SCHWERDTFEG- ER R	2006	Blood2006，108，：	1
16	ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML) 显示文摘	Zander AR Kroger N Schleuning M	2003	Bone Marrow Transplantat2003，32，4：	1
17	Allelic dimorphism in the human tissue-type phaminogen activator(TPA)gene as a result of an Alu insertion/deletion event显示文摘	Ludwig M Wohn KD Schleuning WD	1992	Hum Genet1992，88，4：	1
18	Human parvovirus B19-associated disease in bone marrow transplantation显示文摘	Schleuning M Jager G Holler E	1999	Infect1999，27，2：	1
19	Downstream targets of urokinase-type plasminogen-acvivatormediated signal transduction显示文摘	Hucho F Schleuning WD	1998	Eur J Biochem1998，253，2：	1
20	High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission 显示文摘	SCHMID C SCHLEUNING M HENTRICH M	2008	Bone Marrow Transplant2008，41，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示